Indium 111 Oxyquinolone Solution

Indium 111 Oxyquinolone Solution Manufacturers

• Anazaohealth Corporation
  

  ×

  Indium 111 Oxyquinolone Solution | Anazaohealth Corporation

  

  ---

  The recommended adult (70kg) dose of Indium In-111 Oxyquinoline labeled autologous leukocytes is 7.4 to 18.5 MBq (200-500 μCi). Indium In-111 Oxyquinoline solution is intended for radiolabeling of autologous leukocytes. The Indium In-111 Oxyquinoline labeled autologous leukocytes are administered intravenously.

  Imaging is recommended at approximately 24 hours post injection. Typically, anterior and posterior views of the chest, abdomen and pelvis should be obtained with other views as required. Aseptic procedures and a shielded syringe should be employed in the withdrawal of Indium In-111 Oxyquinoline from the vial. Similar procedures should be employed during the labeling procedure and the administration of the labeled leukocytes to the patient. The user should wear waterproof gloves during the entire procedure. The patient’s dose should be measured by a suitable radioactivity calibration system immediately before administration. At this time, the leukocyte preparation should be checked for gross clumping and red blood cell contamination

  Storage and Handling

  Indium In-111 Oxyquinoline solution should be stored at room temperature (15-25ºC, 59-77ºF)

  Close
  No Recall

  More Info